casetext.com/case/united-states-ex-rel-schumann-v-astrazeneca-pharm-lp-1

Oct 20, 2014 ... Plaintiff Karl S. Schumann, proceeding as a qui tam relator under the False Claims Act (FCA), 31 U.S.C. § 3729 et seq., and corresponding ...

law.justia.com/cases/federal/appellate-courts/ca1/15-2232/15-2232-2017-05-02.html

May 8, 2017 ... Plaintiff appealed the district court's grant of summary judgment in favor of her former employer, AstraZeneca Pharmaceutical LP, on Plaintiff's ...

caselaw.findlaw.com/us-3rd-circuit/1681038.html

ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District ...

www.finnegan.com/en/tools/astrazeneca-lp-v-apotex-inc.html

Case. 09-1381. Venue: Federal Circuit. Judges: Rader, Bryson (concurring-in- part, dissenting-in-part), Linn (author). Date: November 1, 2010.

www.bloomberg.com/news/articles/2018-08-07/astrazeneca-to-pay-110-million-to-settle-texas-drug-suits-jkk6v647

Aug 7, 2018 ... AstraZeneca Plc agreed to pay $110 million to settle a Texas claim alleging that the ... Texas claimed AstraZeneca promoted Seroquel to Medicaid providers who ... The case is the State of Texas v. AstraZeneca LP, No.

www.ncbi.nlm.nih.gov/pmc/articles/PMC5880376

Apr 2, 2018 ... However, the discovery by Liu, et al. ..... All work was performed at IHMA and sponsored by AstraZeneca Pharmaceuticals, LP, which also included compensation fees ... Di Pilato V, Arena F, Tascini C, Cannatelli A, Henrici De Angelis L, Fortunato S, et al. mcr-1.2, a New mcr variant carried on a transferable  ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC6012561

May 31, 2018 ... Filippo de Marinis,1 Fortunato Ciardiello,2 Paul Baas,3 Lucio Crinò,4 Giuseppe Giaccone,5 .... OS was significantly improved in favour of nivolumab (median 9.2 vs 6.0 months, ..... LP-A receiving honoraria AstraZeneca, Pfizer, Bristol-Myers Squibb, MerckSharp ... Passaro A, Lazzari C, Karachaliou N, et al.

citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.612.9214&rep=rep1&type=pdf

Paolo Maione,a Cesare Gridelli,a Teresa Troiani,b Fortunato Ciardiellob. aDivision of Medical .... EGFR-TK Thatcher et al. [9]. Gefitinib vs. best supportive care. Second- or third- line treatment .... tipifarnib (Zarnestra™; Ortho Biotech Products, L.P.,. Bridgewater, NJ) ..... sultant for AstraZeneca and sanofi-aventis. References.

journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0195281&type=printable

Apr 2, 2018 ... sponsored by AstraZeneca Pharmaceuticals, LP, which also included compensation ..... 2016. 15. Di Pilato V, Arena F, Tascini C, Cannatelli A, Henrici De Angelis L, Fortunato S, et al. mcr-1.2, a New mcr variant carried on a ...